Join us for three inspiring days at the ISPE Europe Conference 2022 which this year will focus on the following themes:
- Annex 1
- Digital Quality
- Trends in Pharmaceutical Engineering and Project Management
The program offers an Executive Forum, dynamic keynote speakers, four robust tracks and innovative and attractive plant tours. You don't want to miss this!
Book you in-person or virtual conference pass today!
Get insight from NNE's experts
Want to learn about holistic control strategy? Or maybe you're looing for inspiration for how you can implement more circular thinking? Join the presentations by NNE's Line Lundsberg-Nielsen and Lis Thodberg.
Pharma 4.0 holistic control strategy - the vehicle for speedy, reliable, consistent and predictable product supply
Wednesday 27 April, 16:30 – 17:10 (also available via live stream)
Line Lundsberg-Nielsen, Ph. D., Managing Consultant, Compliance Consulting at NNE
To secure product supply many different control strategies are implemented. However, these are rarely connected so a change to one control strategy may impact another control strategy in an unforeseen way. The Holistic Control Strategy connects the different CS elements across the entire supply chain to secure a robust end-to-end manufacturing process delivering speedy, reliable, consistent quality products throughout the entire product lifetime.
The implementation of the HCS requires different capabilities related to digital, analytical, process, quality, and organisational maturity. This presentation will define and discuss the role of the Holistic Control Strategy and the capabilities required for successful implementation.
Rise of the symbiosis: How pharma can go circular
Wednesday 27 April, 09:30 – 10:00
Lis Thodberg, Director for Health, Safety and Environment at NNE
What does it take for pharma to go circular? First and foremost, it requires that company decision-makers recognize the potential gains. And secondly, that they can establish a collaboration with another company.
This is because the mission for any symbiosis is to think beyond your own operations. It’s the community before the individual. This mind-set enables huge pharma companies like Fujifilm Diosynth Biotechnologies and Novo Nordisk to work together to drive growth and innovation.
In this talk, Lis will present a range of symbiosis examples that all include the pharma industry: The Kalundborg Symbiosis, Symbiosis Hillerød, a new potential Symbiosis in Ballerup, and the Danish national Symbiosis network. In addition, she will present some examples of more generic tools that support the establishment and operation of symbiotic networks.